• Is There a General Preference for the Worse Off? A Discrete Choice Experiment Using Individually Calibrated Health State Valuations

    Sep 1, 2025, 00:00

  • Validity of the EQ-5D-5L for Routine Assessment in Residential Aged Care: Results From a Feasibility Study

    Sep 1, 2025, 00:00

  • Validity and Reliability of the EQ-HWB in Parents of Children With Health Conditions

    Sep 1, 2025, 00:00

  • Author Reply

    Sep 1, 2025, 00:00

  • Optimizing Monte Carlo Sampling in Health-Economic Modeling: Underlying Concepts and Parameter Definitions

    Sep 1, 2025, 00:00

  • Value-Based Care: Lessons for the United Kingdom’s National Health Service

    Sep 1, 2025, 00:00

  • The Cost-Effectiveness of an Artificial Intelligence-Based Population-Wide Screening Program for Primary Open-Angle Glaucoma in The Netherlands

    Sep 1, 2025, 00:00

  • Use and Potential Misuse of Glucagon-Like Peptide-1 Receptor Agonists in France: A Nationwide Cohort Study

    Sep 1, 2025, 00:00

  • Health State Utilities for Achondroplasia: A Time Trade-Off Study

    Sep 1, 2025, 00:00

  • Author Reply

    Sep 1, 2025, 00:00

  • Do We Always Need a New Preference Study? A Scoping Review of Promising Research Areas for Meta-Analyses and Benefit Transfers of Patient Preference Studies

    Sep 1, 2025, 00:00

  • Utility Studies in Rare Diseases: A Systematic Literature Review

    Sep 1, 2025, 00:00

  • Building Blocks of Value Creation Within Value-Based Health Systems: A Delphi Study

    Sep 1, 2025, 00:00

  • Addressing Limitations in the Cost-Effectiveness Analysis of Digitally Supported Care Management for Dementia Caregivers

    Sep 1, 2025, 00:00

  • Editorial Board

    Aug 26, 2025, 09:11

  • Growing Evidence Base on Condition-Specific Patient-Reported Outcome Measures for Long COVID

    Aug 1, 2025, 00:00

  • Implementing the Generalized Risk-Adjusted Cost-Effectiveness Model for Sickle Cell Disease: A Case Study

    Aug 1, 2025, 00:00

  • A Comparative Study of Health and Well-Being Measures in Ireland Using EQ Health and Wellbeing (EQ-HWB) and its Short Version, EQ-5D-5L, and ICEpop Capability Measure for Adults (ICECAP-A)

    Aug 1, 2025, 00:00

  • Understanding the Transition Between Age-Specific Measures of Health-Related Quality of Life: Evidence on the Relationship Between and Comparative Performance of the EQ-5D-Y-5L and EQ-5D-5L

    Aug 1, 2025, 00:00

  • Exemption System for Economic Evaluation Data Submission for Pharmaceuticals in South Korea: Achievements and Challenges

    Aug 1, 2025, 00:00

  • Psychometric Properties of the Modified EQ Health and Wellbeing and its Shorter Version in a General Chinese Population: A Comparative Analysis With EQ-5D-5L, SF-6Dv2, ICEpop CAPability measure for Adults, Short Version of Warwick-Edinburgh ...

    Aug 1, 2025, 00:00

  • The Psychometric Performance of the EQ Health and Wellbeing in Caregivers of Persons Living With Dementia

    Aug 1, 2025, 00:00

  • Early Budget Impact Analysis of Artificial Intelligence to Support the Review of Radiographic Examinations for Suspected Fractures in National Health Service Emergency Departments

    Aug 1, 2025, 00:00

  • Mapping EQ-5D-5L Utilities in Dementia: Integrating Self and Proxy Reports

    Aug 1, 2025, 00:00

  • A Comprehensive View of the Methods Used to Measure the Societal Impact of Healthcare Interventions: A Systematic Review

    Aug 1, 2025, 00:00

  • Costs and Outcomes After Primary and Revision Hip Replacements by Implant Bearing Materials: Analysis of 550 760 linked Patient Records from English Routinely Collected Databases

    Aug 1, 2025, 00:00

  • Realizing the Economic Potential of Meditation and Mindfulness Practices in Mental Health Care

    Aug 1, 2025, 00:00

  • The Burden of Mitochondrial Disease: Healthcare and Societal Costs

    Aug 1, 2025, 00:00

  • The Increasing Use of Clinical Outcome Assessments in US Food and Drug Administration Labels and the German Gemeinsamer Bundesausschuss, National Institute for Health and Care Excellence, and the French Haute Autorité de Santé Assessments F ...

    Aug 1, 2025, 00:00

  • The Value of Hope in Cancer Care: Risk Preference and Heterogeneity in Cancer Patients and the General Public

    Aug 1, 2025, 00:00

  • Distributional Cost-Effectiveness Analysis in Genomic Medicine: Considerations for Addressing Health Equity

    Aug 1, 2025, 00:00

  • An Exploratory Study of Alternative Time Frames and Descriptors for EQ-5D-5L in Obstructive Airway Diseases Using Mixed Methods

    Aug 1, 2025, 00:00

  • Table of Contents

    Aug 1, 2025, 00:00

  • Addressing Subgroup-Specific Treatment Effects to Avoid Inefficient Care: The Conflict Between Statistical and Health Economic Analyses

    Aug 1, 2025, 00:00

  • Synergizing Needs Assessments and Patient Preference Studies for Enhanced Patient-Centered Decision Making in Healthcare

    Aug 1, 2025, 00:00

  • A Systematic Review and Meta-Analysis of Health-State Utility Values for Infectious Diseases With Pandemic Potential and Associated Vaccine Adverse Reactions

    Aug 1, 2025, 00:00

  • The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set

    Aug 1, 2025, 00:00

  • Editorial Board

    Jul 31, 2025, 08:55

  • SA17 Assessing the Impact of Frailty on Healthcare Burden Post-Surgery in Head and Neck Cancer Patients

    Jul 14, 2025, 17:02

  • Editorial Board

    Jul 3, 2025, 09:29

  • HSD114 Access and Quality of Usual Source of Care and Racial/Ethnic Disparities in US Adults with Multiple Chronic Conditions

    Jul 1, 2025, 00:00

  • P31 Using Z Codes to Characterize Health and Social Histories in Commercially Insured Non-Hodgkin Lymphoma Patients: Insights from Real-World Data

    Jul 1, 2025, 00:00

  • EE245 Continuous Avoidance Cost in Biosimilar: A Budget Impact Analysis on the Basis of Clinical Trial Model and RWD in Brazil / LATAM / LMIC

    Jul 1, 2025, 00:00

  • EE490 Novel Value Elements: Developing and Applying a Pragmatic Framework in Early Stages of Product Development

    Jul 1, 2025, 00:00

  • EPH133 Targeted Literature Review and Qualitative Synthesis of the Burden of Oral Corticosteroid-Related Adverse Events in Autoimmune Conditions

    Jul 1, 2025, 00:00

  • HPR3 Determinants of Clinical Trial Participation in Prostate Cancer Patients: A Nationwide Medicare Analysis

    Jul 1, 2025, 00:00

  • CO57 Comparative Clinical Effectiveness of Analgesics for the Treatment of Moderate-to-Severe Acute Pain: A Systematic Review and Network Meta-Analysis

    Jul 1, 2025, 00:00

  • P36 Comparative Analysis of Large Language Models for Extracting Patient-Reported Outcome Measures From Clinical Trial Protocols in Lymphoma

    Jul 1, 2025, 00:00

  • EE314 Cost-Effectiveness Analysis of HIV Prevention and Treatment Portfolios in US Prison Settings

    Jul 1, 2025, 00:00

  • MSR48 Discrete-Event Simulation Model Projects Economic Outcomes Associated with Long-Term Clinical Remission in Patients with Severe Asthma Receiving Mepolizumab

    Jul 1, 2025, 00:00

  • PCR146 Using Machine Learning to Identify Key Predictors of Health-Related Quality of Life in Older Women with Early-Stage Breast Cancer Undergoing Endocrine Therapy

    Jul 1, 2025, 00:00

  • PCR35 Health Utilities Associated With Pneumococcal Diseases in Children and Adults in the United States: A Targeted Literature Review and Meta-Analysis

    Jul 1, 2025, 00:00

  • EE256 Cost-Utility Analysis of Lorlatinib in First-Line Treatment of adult patients with ALK-Positive Advanced Non-Small Cell Lung Cancer (aNSCLC) in Colombia

    Jul 1, 2025, 00:00

  • HPR137 HTA Assessments for Multipurpose Contrast Agents: Insights and Solutions to Formal HTA Challenges

    Jul 1, 2025, 00:00

  • RWD114 Real-World Characteristics and Treatment Patterns With Nintedanib in Patients With Idiopathic Pulmonary Fibrosis: A Retrospective US Claims Study

    Jul 1, 2025, 00:00

  • HSD34 Telehealth for Disease Management: A Scoping Review of Effectiveness in the Perinatal Period

    Jul 1, 2025, 00:00

  • HPR46 Gender Differences in Use of Cerebrospinal Fluid Biomarker Test and Positron Emission Tomography for Diagnosing Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias in the Real World Setting

    Jul 1, 2025, 00:00

  • HPR149 Analysis of 20 Years of Legislative Trends to Predict Future Investment and Access to Orphan Drugs

    Jul 1, 2025, 00:00

  • PCR1 Health-Related Quality of Life Research in Jordan: A Systematic Review of Published Studies

    Jul 1, 2025, 00:00

  • PCR22 Differences in Demographic and Clinical Profiles Among Patients Adherent Vs. Non-Adherent to Revefenacin Following a COPD-Related Hospitalization

    Jul 1, 2025, 00:00

  • SA4 Relationship Between Event-Free Survival (EFS) and Overall Survival (OS) in Newly Diagnosed Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)

    Jul 1, 2025, 00:00

  • RWD27 COVID Impact on Cardiac Implantable Eletronic Devices Trends in the Brazilian Public Health System: a Joinpoint Regression Analysis

    Jul 1, 2025, 00:00

  • EE233 Cost and Prevalence of Pre-Analytical Errors: A Narrative Review

    Jul 1, 2025, 00:00

  • PCR125 Patients' Experiences With Prescription Opioid Use for Acute and/or Chronic Pain Management: A Qualitative Study

    Jul 1, 2025, 00:00

  • RWD42 Predictive Models and Risk Scoring System Development for Assessing Survival in Uterine Cancer Patients With Type 2 Diabetes Mellitus: A Territory-Wide Cohort Study

    Jul 1, 2025, 00:00

  • EE471 Patient Value Assessment Using a Unified Measure Based on Data Envelopment Analysis: A Case Study

    Jul 1, 2025, 00:00

  • CO39 Risk of Cutaneous Adverse Drug Reactions with GLP-1 Receptor Agonists: Insights from FAERS and Systematic Review

    Jul 1, 2025, 00:00

  • HSD7 Development of Hungarian One-Day Surgical Care in the Public-Funded National Healthcare System From 2010 to 2023

    Jul 1, 2025, 00:00

  • HTA81 Development of a Novel Value Framework for Evaluating Population Genomic Programs Using A Mixed Methods Approach

    Jul 1, 2025, 00:00

  • EPH188 Economic Modelling of Myopia Management: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • P43 IPDvariate: Reconstructing Patient Characteristics and Survival Data from Kaplan-Meier Curves for Subgroup Analysis

    Jul 1, 2025, 00:00

  • HSD6 The Impact of One-Day Surgery Performance Indicators on Hospital Capacities in Hungary

    Jul 1, 2025, 00:00

  • CO19 Adherence to Nucleos(t)ide Analog Therapies in Chronic Hepatitis B: A Systematic Review

    Jul 1, 2025, 00:00

  • HSD113 Characterization of the Trajectories of Care Post-Liver Transplant Recipients From Virginia Using Real World Data

    Jul 1, 2025, 00:00

  • PCR111 Tracking Patterns in Sleep Disturbances During Flare-Ups in Patients With Atopic Dermatitis: Insights From an App-Based Digital Health Tracking Study

    Jul 1, 2025, 00:00

  • EPH3 Assessing Prescribing Trends for Select Glucagon-Like Peptide Receptor Agonists (GLP-1s) by Patient Demographics, Providers, and Indication

    Jul 1, 2025, 00:00

  • PCR170 Post-DCE Qualitative Interviews: A Novel Method to Understand the Rationale for Stated Preferences - An Example Among Patients and Physicians in Severe Asthma

    Jul 1, 2025, 00:00

  • PCR32 Informal Caregivers' Attitudes Towards Robots in Hungary and Poland

    Jul 1, 2025, 00:00

  • MSR23 Does Our Instrument Include the Right Response Options? Empirical Evidence to Evaluate Floor and Ceiling Effects for Multi-Item Ordinal Instruments

    Jul 1, 2025, 00:00

  • MT42 Bench Study Assessing the Impact of the Next Generation of Vitreoretinal-Cataract System on System Set-Up and Tear-Down Time for Vitreoretinal Surgery

    Jul 1, 2025, 00:00

  • PCR104 A Conceptual Model of Multiple Myeloma Symptoms and Impacts, and A Characterization of Pain Among Patients Living With Relapsed/Refractory Multiple Myeloma

    Jul 1, 2025, 00:00

  • RWD139 Burden Of Hidradenitis Suppurativa In The Brazilian Private Healthcare System

    Jul 1, 2025, 00:00

  • HPR49 Formulary Inclusion for Oncologic Indications: Comparing FDA-Approved Indications and Off-Label Compendia Support

    Jul 1, 2025, 00:00

  • P40 Cost-Effectiveness Analysis of Second-Generation Antipsychotic Long-Acting Injectables in Patients with Schizophrenia in the United States

    Jul 1, 2025, 00:00

  • PT34 Response Performance of General Chinese Children Aged 6-11 to EQ-5D-Y-3L: A Multicenter Study

    Jul 1, 2025, 00:00

  • Research Method, Conduct, and Reporting Considerations for Improving the Quality of Non-Hypothesis-Evaluating Treatment Effectiveness Analyses Using Real-World Data: An ISPOR Working Group Report

    Jul 1, 2025, 00:00

  • EPH93 Protocol for a Real-World Retrospective Study on Cardiovascular Outcomes in Japan Comparing Heated Tobacco Product Users, Cigarette Smokers, Former Smokers, and Never Smokers

    Jul 1, 2025, 00:00

  • MSR47 Using the Potential Outcomes Model to Inform the Design and Interpretation of Causal Studies of the Effectiveness and Safety of Healthcare Interventions: An Interdisciplinary Perspective

    Jul 1, 2025, 00:00

  • HSD45 US Physician Characteristics Associated With Real-World Evidence Implementation in Oncology Practice

    Jul 1, 2025, 00:00

  • HPR103 Comparing Medicare Maximum Fair Prices with Other Drug Prices in Other Countries

    Jul 1, 2025, 00:00

  • OP11 Audience and Publication Profiles in HEOR Research: A Cross-Sectional Analysis of Non-Small-Cell Lung Cancer and Coronary Artery Disease Studies in 2024

    Jul 1, 2025, 00:00

  • HTA54 Cost-Effectiveness Analysis of Olaparib and Niraparib With Abiraterone Versus Abiraterone for First-Line Treatment of BRCA Mutated Metastatic Castration-Resistant Prostate Cancer in Taiwan

    Jul 1, 2025, 00:00

  • HTA41 Evaluating PICOs Requested by Member States During Scoping for EU HTA Versus Those Covered in Actual HTAs

    Jul 1, 2025, 00:00

  • CO33 Comparison of Suicidal Ideation or Personal History of Self Harm Among Patients with Use of Rexulti and All Antipsychotics

    Jul 1, 2025, 00:00

  • P37 Trial-Based Economic Evaluation of the BrainACT Study: Acceptance and Commitment Therapy for Anxiety and/or Depressive Symptoms After Acquired Brain Injury in the Netherlands

    Jul 1, 2025, 00:00

  • EPH132 Administrative Frequency of Alopecia Areata and Clinical Characteristics in a Colombian HMO: a Real-World Data Characterization For 2015-2023

    Jul 1, 2025, 00:00

  • HPR19 Racial Disparity in Healthcare Expenditure Among Older Adults with Cardiovascular Diseases

    Jul 1, 2025, 00:00

  • HSD107 Individualized Electronic Patient Reported Outcome Measures as a Communication Aid in Outpatient Cardiology Care

    Jul 1, 2025, 00:00

  • P20 The Past, Present, and Future of Demand for Bariatric Surgery in Chile: A Subgroup Analysis for no-income (Group A) FONASA Beneficiaries

    Jul 1, 2025, 00:00

  • Quantifying the Impact of Intervention on Health Outcomes: A Tool for Assessing Incremental Changes to Life Expectancy

    Jul 1, 2025, 00:00

  • PCR70 The Impact of Information and Under-Information on Quality of Life in People With Polycystic Ovary Syndrome

    Jul 1, 2025, 00:00

  • EPH97 Overall Survival in People Living with HIV, Who Experienced Progressive Multifocal Leukoencephalopathy

    Jul 1, 2025, 00:00

  • HSD31 Identification of Barriers to and Practical Strategies for Increasing Clinical Trial Diversity: A Scoping Review

    Jul 1, 2025, 00:00

  • EPH63 Global Analysis of the Epidemiological Burden of Osteoarthritis based on Data from the Global Burden of Disease Study

    Jul 1, 2025, 00:00

  • RWD21 Development and Validation of a Claims-Based Approach to Identify Patients with Metastatic Triple Negative Breast Cancer (mTNBC)

    Jul 1, 2025, 00:00

  • SA2 Assessing the Feasibility of Indirect Comparisons of Vaccines: A Framework for Network Meta-Analysis

    Jul 1, 2025, 00:00

  • CO10 A Real-World Retrospective Cohort Study Characterizing Patients with MMN in the United States

    Jul 1, 2025, 00:00

  • HPR165 Application of England's Severity Weighting to Cost-Effectiveness Evaluations in Japan

    Jul 1, 2025, 00:00

  • HTA40 The Role of Real-World Evidence in Addressing Gaps in Health Technology Assessment in Brazil’s Public Healthcare System

    Jul 1, 2025, 00:00

  • EE454 Economics of Prostate Cancer in Canada: A Systematic Review

    Jul 1, 2025, 00:00

  • HPR12 Exploring the Equity of Out-of-Pocket Healthcare Expenses and Catastrophic Healthcare Expenditures in Taiwanese Households

    Jul 1, 2025, 00:00

  • HSD30 Characterization of Patients With Desmoid Tumors (DT) and Their Treatment Patterns Within an Academic Health System in the United States

    Jul 1, 2025, 00:00

  • SA8 A Comparison of Single-Network and Multi-Site Approaches to Real-World Data Collection

    Jul 1, 2025, 00:00

  • EE464 Economic and Healthcare Burden in Patients with Sjögren's Syndrome: A Systematic Review

    Jul 1, 2025, 00:00

  • MSR129 Healthcare Resource Utilization Disruptions During the COVID-19 Era and Methodological Considerations: A Review

    Jul 1, 2025, 00:00

  • EPH4 All for One and One for All? Patterns of Familial Influenza Vaccination

    Jul 1, 2025, 00:00

  • EE326 A Cost Per Responder Analysis of Ritlecitinib and Baricitinib: Assessing the Impact of Clinical Efficacy and Dosing Variability on Overall Treatment Costs of Severe Alopecia Areata (AA)

    Jul 1, 2025, 00:00

  • EE373 Utilization of Adalimumab and Infliximab Biologics and Biosimilars in Rheumatoid Arthritis Patients

    Jul 1, 2025, 00:00

  • PCR39 Patient-Centered Research (Patient-Reported Outcomes and Quality of Life Outcomes)

    Jul 1, 2025, 00:00

  • PT7 Selection and Stability of Parametric Bivariate Copula Models for Joint Modelling of Overall and Progression-Free Survival

    Jul 1, 2025, 00:00

  • PT28 Evaluation of Measurement Properties of Health Assessment Questionnaire Disability Index (HAQ-DI) among Gout Populations in China

    Jul 1, 2025, 00:00

  • MSR109 Artificial Intelligence Integration in Health Technology Assessments: A Review of Global Policies and Practices

    Jul 1, 2025, 00:00

  • MSR106 Breaking Linguistic Barriers: Cross-Language HEOR Evidence Integration Through GenAI

    Jul 1, 2025, 00:00

  • MSR70 Using Machine Learning to Estimate Perceptions and Future Prescribing Intentions of Health Care Providers: A Novel Application of Integrated Primary and Secondary Data in Understanding HCP Decision-Making

    Jul 1, 2025, 00:00

  • RWD36 Accelerating EHR Insights: NLP-Driven Data Abstraction in Gallbladder Cancer

    Jul 1, 2025, 00:00

  • RWD88 Real World Treatment Patterns, Genetic Testing, and Clinical Outcomes among Patients with mCRPC Treated with Olaparib Monotherapy in US Urology Clinics

    Jul 1, 2025, 00:00

  • EPH128 Changes in the Prevalence of Pregnancy Complications During the COVID-19 Pandemic: Is Increased Prevalence the New Normal?

    Jul 1, 2025, 00:00

  • CO89 Persistence of Infliximab Biosimilar versus Originator in Patients with Crohn's Disease: a Retrospective Cohort Study in China

    Jul 1, 2025, 00:00

  • EE429 Economic Burden of HER2+ Breast Cancer and the Targeted Therapies Epidemiological Economic Impact in Trinidad and Tobago

    Jul 1, 2025, 00:00

  • EE298 Optimized Treatment Sequences for ALK+ Stage IV NSCLC: Cost-Effectiveness Analysis From RCT data and Real-World Evidence

    Jul 1, 2025, 00:00

  • MSR87 Using Regression Discontinuity in Time Design for Real-World Comparative Effectiveness: A Case Study for the Second-Line Use of Pembrolizumab in Advanced Non-Small Cell Lung Cancer

    Jul 1, 2025, 00:00

  • RWD121 Economic and Health Care Resource Utilization (HCRU) Burden of Acute Myocardial Infarction (AMI) With or Without Systemic Inflammation in US Hospitals: A Real-World Study

    Jul 1, 2025, 00:00

  • EE311 The Equitable Quality-Adjusted Life-Year

    Jul 1, 2025, 00:00

  • MSR50 Balancing Baseline Characteristics With SMOTE and Propensity Score Weighting in a Comparative Study of PASCAL Transcatheter Valve Repair and Medical Therapy for Degenerative Mitral Regurgitation

    Jul 1, 2025, 00:00

  • EPH57 Administrative Incidence and Prevalence of Multiple Myeloma Using Administrative Claims Data From a Large Health Maintenance Organization in Colombia, 2015–2023

    Jul 1, 2025, 00:00

  • HSD105 Development and Validation of a Machine Learning-Based Prediction Model for 30-Day COPD Readmissions: Enhancing Early Risk Stratification and Intervention

    Jul 1, 2025, 00:00

  • P41 Incorporating External Opinion in Survival Extrapolations to Inform Long-Term Survival Projections for Health Technology Assessment

    Jul 1, 2025, 00:00

  • EE244 Economic Feasibility of 'Pay One Price': An Analysis of Three Biosimilar Molecules with Different Prices and Indicated for Rheumatoid Arthritis in a Medium Size HMO

    Jul 1, 2025, 00:00

  • HPR13 Are Commercial Insurance Premiums Associated With the 340B Drug Pricing Program?

    Jul 1, 2025, 00:00

  • EE301 Cost-effectiveness Analysis of Zavegepant in Acute Migraine Treatment

    Jul 1, 2025, 00:00

  • EE445 Risk of Hospital Readmission Among Adults Aged 50 Years and Older Hospitalized With Respiratory Syncytial Virus (RSV) or Influenza

    Jul 1, 2025, 00:00

  • EPH176 Depression Among Rheumatoid Arthritis Patients Using the Medical Expenditure Panel Survey Database

    Jul 1, 2025, 00:00

  • RWD3 The Relationship Between Weight and Disease Severity in Dogs with Chronic Kidney Disease: Results from a Real-World Study

    Jul 1, 2025, 00:00

  • HSD63 Perspectives on Real-World Management of Stomatitis/Oral Mucositis (S/OM) From Oncologists With Experience Treating Patients With Metastatic Non-Small Cell Lung Cancer (mNSCLC) and Metastatic Breast Cancer (mBC)

    Jul 1, 2025, 00:00

  • PCR191 Impact Of Valbenazine On Improvements In Health-Related Quality of Life (HRQoL) In Patients With Tardive Dyskinesia (TD): EQ-5D-5L Results From A Phase 4 Randomized Withdrawal Study (NCT03891862)

    Jul 1, 2025, 00:00

  • PCR3 Changes in Functional Status, Work Productivity, and Daily Activities in People With Idiopathic Hypersomnia and Narcolepsy Treated With Low-Sodium Oxybate: Results From the Phase 4 DUET Study

    Jul 1, 2025, 00:00

  • PCR67 Assessing the Feasibility of Using an Electronic Platform for Personalized Outcome Assessment: GoalNav for Goal Attainment Scaling

    Jul 1, 2025, 00:00

  • EE377 What is the Role of Humans in a World of Artificial Intelligen An Exploratory Economic Evaluation of Human-AI Collaboration in Diabetic Retinopathy Screening

    Jul 1, 2025, 00:00

  • MSR56 Comparison of AI-Enhanced Tools for Automating Scientific Literature Reviews

    Jul 1, 2025, 00:00

  • PCR215 Self-Reported Health-Related Quality-of-Life in Adolescent Patients with Complex Chronic Health Conditions from A Longitudinal Registry Study in Los Angeles County

    Jul 1, 2025, 00:00

  • MSR27 Barriers to CAR-T Therapy Access in the U.S.: A County-Level Analysis of Proximity and Sociodemographic Factors

    Jul 1, 2025, 00:00

  • RWD105 Benchmarking Disease Prevalence in a Large Scale Electronic Health Record Data Network: An Assessment of Chronic and Rare Disease in the United States in 2023

    Jul 1, 2025, 00:00

  • EPH141 Effectiveness of Early Remdesivir Initiation in Patients with Immunocompromising Conditions Hospitalized with COVID-19 by Variant Era, Level of Immunocompromise, and Age

    Jul 1, 2025, 00:00

  • HPR135 Learnings from State and Federal Drug Pricing Negotiations Across the United States: the Impact of Prescription Drug Affordability Boards

    Jul 1, 2025, 00:00

  • HTA75 The Effectiveness of an Individualized eHealth Application on Glycemic Control in Diabetes Patients: A Randomized Controlled Trial

    Jul 1, 2025, 00:00

  • RWD155 Real-World Treatment Patterns and Outcomes in Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Treated With First-Line Platinum-Based Chemotherapy (PBC) and =2 Subsequent Lines of Therapy in the United States

    Jul 1, 2025, 00:00

  • MSR95 Sizing Up the Gap: Evaluating Sample Size Justification in Prospective Real-World Studies

    Jul 1, 2025, 00:00

  • MSR24 Leveraging Machine Learning to Assess the Association of Rash and Survival in Patients With Advanced NSCLC

    Jul 1, 2025, 00:00

  • RWD47 Healthcare Resource Utilization 12 Months Following Initiation of Olanzapine/Samidorphan: Real-World Assessment of Patients With Schizophrenia

    Jul 1, 2025, 00:00

  • MSR147 Evaluating Imaging Artificial Intelligence (AI) Matching Real-World Digital Twins (rwDTs) Into an External Control Arm (ECA) for MYSTIC: A Phase 3 Clinical Trial in Metastatic Non-Small Cell Lung Cancer (mNSCLC)

    Jul 1, 2025, 00:00

  • MSR41 The Use of Large Language Models for Systematic Literature Review Automation: An Evaluation of Quality and Time Savings

    Jul 1, 2025, 00:00

  • HSD81 A Real-World Perspective of Quadruple Treatment Patterns for 1L Multiple Myeloma Patients across North and South America, Europe and Asia

    Jul 1, 2025, 00:00

  • HPR156 The Inflation Reduction Act: Evaluating Impact on Medicare Drug Pricing, Innovation, and Access to Therapies

    Jul 1, 2025, 00:00

  • EE386 Assessing the Impact of Exagamglogene Autotemcel (Exa-cel) on Health Inequalities in Patients with Sickle Cell Disease in the United Kingdom and Canada

    Jul 1, 2025, 00:00

  • MSR44 Going Beyond Excel vs. R: An Introduction To Visual Programming for Health Economics Modelling

    Jul 1, 2025, 00:00

  • RWD41 Shifting Landscapes: Rising Trends in Breast and Colon Cancer Screenings and Diagnoses

    Jul 1, 2025, 00:00

  • PT39 Best Practices and Standards to Enhance the Quality of Rare Disease Registries in Canada

    Jul 1, 2025, 00:00

  • HPR133 Coverage Gaps: Do U.S. Commercial Health Plans Have Concordant Alzheimer's Disease Therapy Testing Policies?

    Jul 1, 2025, 00:00

  • HSD17 Co-Design of a Discrete Choice Experiment for Revascularization Decisions in Complex Coronary Heart Disease: Importance of Patient Perspectives

    Jul 1, 2025, 00:00

  • CO32 Socioeconomic Status and Anti-obesity Medications: Impact on Cardiovascular Risk in Medicare Patients with Obesity

    Jul 1, 2025, 00:00

  • RWD161 The Contribution of Lab Results Data Linked to Claims Data in Identifying Chronic Kidney Disease Staging

    Jul 1, 2025, 00:00

  • RWD83 Variation in Provider Reimbursement for Biosimilars and Reference Biologics by Commercial Health Plans

    Jul 1, 2025, 00:00

  • RWD68 AUVI-Q vs. Other Epinephrine Auto-Injector Prescription Was Associated With Reduced Inpatient Hospitalizations for Anaphylaxis in a US Retrospective Commercial Claims Analysis

    Jul 1, 2025, 00:00

  • MSR132 Association Between Initiation of ENDS and Cigarette Smoking Reduction: A Causal Time Zero Approach to the PATH Study

    Jul 1, 2025, 00:00

  • EE466 Budget Impact Analysis of the Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for disease prevention among Colombian Infants

    Jul 1, 2025, 00:00

  • PCR55 Parental Self-Efficacy in the Management of Pediatric Type 1 Diabetes Mellitus: A Subgroup Analysis Among CGM Sensor Users

    Jul 1, 2025, 00:00

  • HSD77 Patient and Diagnostic Delay in Patients With Breast or Colorectal Cancer

    Jul 1, 2025, 00:00

  • PCR33 Development of New Patient Reported Outcome (PRO) Conceptual Models for Treatment Adherence and Satisfaction in People with HIV

    Jul 1, 2025, 00:00

  • OP10 The Impact of Research Sessions on Pharmacy Students’ Perceived Understanding in Research Design and Methodology

    Jul 1, 2025, 00:00

  • EE369 Healthcare Resource Utilization (HCRU), Costs, and Outcomes Among Patients With Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) in the United States: A Retrospective, Real-World Analysis of Administrative Claims Data

    Jul 1, 2025, 00:00

  • RWD141 Impact of Social Determinants of Health on Severe Maternal Morbidity and Pregnancy Outcomes

    Jul 1, 2025, 00:00

  • HTA56 A Targeted Review of the Application of Discrete Event Simulation Modeling in CDA-AMC Assessments

    Jul 1, 2025, 00:00

  • PCR142 Utility Over Multiple Health Indexes in Non-Small Cell Lung Cancer: Survey Estimates for Patient-Centered Generalized Risk-Adjusted Cost-Effectiveness (GRACE)

    Jul 1, 2025, 00:00

  • EPH71 Expected vs. Observed Mortality Rates, Expressed As Number Needed to Treat, From a Phase 3 Clinical Trial Program of Patients With Hyperphagia and Prader-Willi Syndrome Treated With Diazoxide Choline Extended Release (DCCR)

    Jul 1, 2025, 00:00

  • PCR95 State of Inclusion of Patient-Centered Endpoints in Duchenne Muscular Dystrophy (DMD) Clinical Trials

    Jul 1, 2025, 00:00

  • EE422 Integrating Metrics of Environmental Sustainability into Economic Evaluations: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • EE313 Epidemiology, Healthcare Resource Utilization, and Costs of Unresectable Locally Advanced or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma in China

    Jul 1, 2025, 00:00

  • HSD27 Choosing Wisely?' Use of Staging Imaging in US Veteran Patients With Prostate Cancer

    Jul 1, 2025, 00:00

  • HSD35 Treatment Patterns in the Management of Multiple Myeloma in a Colombian HMO During 2015–2023: A Real-World Data Study

    Jul 1, 2025, 00:00

  • MSR34 Development of a Novel Approach to Improve Binary Classification Prediction Tasks When Encountering Time-To-Event Data: Performance Comparison of Three Alternative Approaches To Predict Stimulant Use Disorder Among Persons Authorized ...

    Jul 1, 2025, 00:00

  • PT21 US Commercial Health Plan Coverage of Oncology Therapies: 2017 - 2024

    Jul 1, 2025, 00:00

  • HSD52 Understanding Barriers to the Early Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease from the Perspective of Physicians and Patients: Results from a Real-World Survey in Germany

    Jul 1, 2025, 00:00

  • HSD48 Uncovering the Cost of Red Blood Cell (RBC) and Platelet (PLT) Transfusions in Africa, Asia, Oceania, and the Americas and Exploring Related Implications in a Trial Example

    Jul 1, 2025, 00:00

  • MSR123 Standardized Tools for Constructing DAGs - Advancing Causal Inference and Risk Assessment in Pharmaceutical Studies

    Jul 1, 2025, 00:00

  • MSR127 The Role of Absolute Summaries in Detecting Intransitivity and Model Mis-Specification in Indirect Treatment Comparisons

    Jul 1, 2025, 00:00

  • CO73 Identifying Risk Factors of Flare(s) in Patients With SLE After Glucocorticoids (GC) Withdrawal (7.5mg) across 1.5 Years

    Jul 1, 2025, 00:00

  • PCR12 Hemolytic Disease of the Fetus and Newborn (HDFN): A Mixed-Methods Preference Study

    Jul 1, 2025, 00:00

  • MSR31 Using Artificial Intelligence to Predict Patient's Preferences

    Jul 1, 2025, 00:00

  • CO15 Exploring the Relationship Between Hemoglobin Levels and Clinical Outcomes in Anemic Dialysis-Dependent Chronic Kidney Disease Patients

    Jul 1, 2025, 00:00

  • P15 Boosting Predictive Power: Thoughtfully Unleashing the Potential of Machine Learning In Real-World Healthcare Outcome Estimation

    Jul 1, 2025, 00:00

  • EE394 Health Economic Impact of Introducing an Adult-Focused 21-valent PCV in the Canadian Adult Population

    Jul 1, 2025, 00:00

  • PT31 Psychometric Testing of the ICECAP-A in Patients With Coeliac Disease: A Comparative Analysis With EQ-5D-5L

    Jul 1, 2025, 00:00

  • EE475 Description and Healthcare Resource Utilization of Patients With Moderate or Severe Lupus Using US Insurance Claims

    Jul 1, 2025, 00:00

  • EE407 The Cost-effectiveness Analysis of Gene Therapy for Severe Hemophilia B Patients in China: A Microsimulation Experiment Study

    Jul 1, 2025, 00:00

  • HPR1 Trends in FDA Approvals of Cardiovascular Drugs from 1980 to 2024

    Jul 1, 2025, 00:00

  • EPH174 Sociodemographic Determinants and Inequities in Prenatal Healthcare in the Canadian Province of Manitoba: A Population-Based Cohort Study 2010-2022

    Jul 1, 2025, 00:00

  • RWD119 Identification and mapping of Real-World Data Sources for Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)

    Jul 1, 2025, 00:00

  • PCR204 Over 30 Years of Discrete Choice Experiment Studies in Health Economics: Systematic Review of Current Practice and Reflections on Evolving Practice

    Jul 1, 2025, 00:00

  • EE312 Absenteeism and Presenteeism Associated With Chronic Conditions in a Canadian Working Population

    Jul 1, 2025, 00:00

  • RWD97 Real-World Treatment Patterns of Metastatic EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Patients from the Integra Connect Database

    Jul 1, 2025, 00:00

  • EPH11 Adverse Events Associated With Recently Approved Alzheimer's Drugs: A Real-World Pharmacovigilance Study

    Jul 1, 2025, 00:00

  • EE238 Eosinophilic Esophagitis-Related Healthcare Resource Utilization: A Retrospective Cohort Study of US Health Insurance Claims Data

    Jul 1, 2025, 00:00

  • HPR152 Characterizing Social Determinants of Health in the Population Receiving Respiratory Syncytial Virus Vaccination in a Nationwide Pharmacy Chain in the United States

    Jul 1, 2025, 00:00

  • HTA65 An Overview of Pricing and Reimbursement Frameworks for Medicinal Products in Central and Eastern European (CEE) Countries: Mechanisms, Rules, And Managed Entry Agreements (MEAs)

    Jul 1, 2025, 00:00

  • MSR105 Stability of a Large Language Model for Data Extraction in Systematic Literature Reviews

    Jul 1, 2025, 00:00

  • PCR255 Landscape of Patient-Reported Outcomes Measures (PROMs) in Oncology Trials: Key Insights Into Patient Voice and Value

    Jul 1, 2025, 00:00

  • PCR145 Health-Related Quality of Life and Productivity Losses Across Stages of Breast and Colorectal Cancer

    Jul 1, 2025, 00:00

  • EE484 A Return On Investment Evaluation Of An Antibiotic Audit And Feedback Program Among Family Physicians

    Jul 1, 2025, 00:00

  • HSD80 Assessing Real-World Dosing Patterns for Vesicular Monoamine Transporter-2 Inhibitors (VMAT2i), Valbenazine and Deutetrabenazine, Among Patients with Tardive Dyskinesia (TD) in a Nationwide US Claims Database

    Jul 1, 2025, 00:00

  • RWD118 Does Health Plan Enrollment Data Support Long-term Follow-up of Patients with Chronic Disease? Assessment of the Healthcare Integrated Research Database (HIRD®)

    Jul 1, 2025, 00:00

  • Mapping the Kidney Disease Quality-of-Life Questionnaire Onto the EQ-5D-5L Utility Index in Patients Undergoing Hemodialysis

    Jul 1, 2025, 00:00

  • MSR9 Using Autonomous Generative AI Agents for Data Extraction from Clinical Study Reports: Accuracy Assessment Against Canada's Drug Agency Reports

    Jul 1, 2025, 00:00

  • MSR5 Translation, Cross-Cultural Adaptation and Psychometric Evaluation of the Yoruba Version of Musculoskeletal Health Questionnaire

    Jul 1, 2025, 00:00

  • OP4 Perception Gap Between Preceptors and Pharmacy Students on Clinical Pharmacy Practice Education (CPPE) in Hospital Pharmacy

    Jul 1, 2025, 00:00

  • PCR221 Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality of Life (HRQoL) Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

    Jul 1, 2025, 00:00

  • HPR55 Assessing the Impact of the United States (US) Inflation Reduction Act (IRA) Regulations on Investment Incentives for Orphan Disease Drug Development

    Jul 1, 2025, 00:00

  • EE214 Cost-Utility Analysis of Faricimab Versus Aflibercept in Treating Neovascular Age-Related Macular Degeneration (nAMD) in the United States

    Jul 1, 2025, 00:00

  • HPR128 Cost of Vaccine Misinformation on the US Healthcare System

    Jul 1, 2025, 00:00

  • RWD120 Comparison of Demographics and Clinical Characteristics Using Real World Data from Tempus Multimodal Database and SEER Cancer Registry Across 17 Solid Cancer Cohorts

    Jul 1, 2025, 00:00

  • RWD20 Real-World Effectiveness of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in Poland in Comparison With Efficacy Reported in Clinical Trials

    Jul 1, 2025, 00:00

  • PCR236 Examining The Association Of Self-Reported Condition Severity And Excessive Daytime Sleepiness Severity With Health-Related Outcomes Among Individuals With Narcolepsy In The United States

    Jul 1, 2025, 00:00

  • MSR120 Estimating Sample Size for Training Ensemble Machine Learning Models

    Jul 1, 2025, 00:00

  • CO69 Combining Patient Clustering and Quantitative Benefit-Risk Assessment in the Comparison of Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention

    Jul 1, 2025, 00:00

  • MSR72 Integrating Artificial Intelligence (AI) and Machine Learning (ML) Techniques With Real-World Data (RWD) and Real-World Evidence (RWE) to Inform Precision Medicine: A Scoping Review

    Jul 1, 2025, 00:00

  • HPR24 Moving the Needle: Value and Use of Real-World Evidence in Oncology Clinical Pathways Decision-Making

    Jul 1, 2025, 00:00

  • HPR4 Evolving HTA and Potential EU HTAR Ripple Effects in the US: Insights From a Stakeholder Survey

    Jul 1, 2025, 00:00

  • PCR232 Patient's Experience of Ulcerative Colitis: A Conceptual Model Based on Qualitative Interviews

    Jul 1, 2025, 00:00

  • MSR20 Discordance Between Two Claims-Based Frailty Indices in a Hospitalized Medicare Population

    Jul 1, 2025, 00:00

  • P25 HELMET: A Benchmark Dataset for Evaluating Generative AI in Health Economics and Outcomes Research

    Jul 1, 2025, 00:00

  • MT4 Exploring Mobile and Wearable Technology for Early Depression Detection and Monitoring

    Jul 1, 2025, 00:00

  • PCR59 Exploring Patient Preferences for Systemic Treatments in Psoriasis: A Review of the Literature

    Jul 1, 2025, 00:00

  • EPH127 Assessment of Racial Disparities in Prenatal Flu Vaccination in the United States

    Jul 1, 2025, 00:00

  • MSR92 The Importance of Specifying the Estimand in Meta-Analyses in the Presence of Treatment Switching

    Jul 1, 2025, 00:00

  • RWD108 A1c Improvement After Initiating Real-Time Continuous Glucose Monitoring Among People with Type 2 Diabetes Not on Insulin Therapy

    Jul 1, 2025, 00:00

  • RWD79 Retrospective Analysis of Cannabis Hyperemesis Syndrome (CHS) Using US Electronic Medical Records: Demographics and Clinical Characteristics

    Jul 1, 2025, 00:00

  • PCR46 The Association Between COVID-19 Vaccination and Health-Related Quality of Life and Work Productivity: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • PCR10 Discontinuation Rates of Once-Weekly GLP-1 Receptor Agonists (GLP-1 RAs) in Patients With Type 2 Diabetes

    Jul 1, 2025, 00:00

  • RWD160 Optimizing Adherence to Intravenous Iron: A Geographic Analysis of Variability Within the United States

    Jul 1, 2025, 00:00

  • HSD69 Patient Characteristics and Treatment Patterns in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

    Jul 1, 2025, 00:00

  • MSR26 Sentence-Level Abstract Section Classification in HEOR Literature using a Biomedical Language Model

    Jul 1, 2025, 00:00

  • EPH68 Mortality trends in Centenarians in Colombia, 2008 - 2022

    Jul 1, 2025, 00:00

  • HSD66 Environmental Impact of Digital Remote Care Versus Standard Care for CML Patients

    Jul 1, 2025, 00:00

  • EE372 Cost-Effectiveness Analysis of Lenvatinib vs Key Comparators in First-Line Unresectable Hepatocellular Carcinoma in Canada

    Jul 1, 2025, 00:00

  • PCR77 Development of a Conceptual Model of the Patient Experience with Idiopathic Hypersomnia: Patient Interviews from a Clinical Trial (NCT05156047)

    Jul 1, 2025, 00:00

  • MSR133 A Comprehensive Review of Real-World Evidence (RWE) Use in Submissions to Canada's Drug Agency (CDA)

    Jul 1, 2025, 00:00

  • MSR122 MetaSLR: AI-Driven Screening and Extraction Platform with Integrated Quality Assurance Checkpoints

    Jul 1, 2025, 00:00

  • HTA25 Assessing Disease Severity: How HTA Bodiea Evaluate Unmet Needs and Influemce Decision-Making

    Jul 1, 2025, 00:00

  • EPH45 Evaluating the National and Regional Prevalence and Incidence Rates of Hepatitis Delta Virus Among Patients With Hepatitis B Virus Infection in Italy

    Jul 1, 2025, 00:00

  • EE268 Cost-Effectiveness Analysis of Mirvetuximab Soravtansine in FRa-Positive Platinum-Resistant Ovarian Cancer in Japan

    Jul 1, 2025, 00:00

  • RWD12 Patient-Reported Symptoms and Quality of Life: A Real-World Survey of Patients With Muscle Invasive Bladder Cancer

    Jul 1, 2025, 00:00

  • MSR141 Reconciling Discrepancies in Results with Different Population-adjusted Indirect Comparison (PAIC) Methods

    Jul 1, 2025, 00:00

  • P38 Cost-Effectiveness of Belimumab for the Treatment of Adults With Active Lupus Nephritis in Canada

    Jul 1, 2025, 00:00

  • EE495 Economic Impact of Experiential Negative Symptoms Among Patients Living With Schizophrenia: Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • PCR157 Estimated Impact of Pre-Exposure Prophylaxis for COVID-19 on Quality of Life and Physical Distancing Among Immunocompromised Individuals and Caregivers

    Jul 1, 2025, 00:00

  • MSR142 Performance Assessment and Validation of Real-World Response Data Generated Using a Deep Learning-Based Natural Language Processing Model Across Multiple Solid Tumors

    Jul 1, 2025, 00:00

  • EE461 Costs And Healthcare Resource Utilization In Patients With Transthyretin Amyloid Cardiomyopathy: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • Cost-Utility Analysis of Durvalumab and Tremelimumab Versus Best Supportive Care in Refractory Metastatic Colorectal Cancer

    Jul 1, 2025, 00:00

  • EE402 Cost-Effectiveness Analysis of Eladocagene Exuparvovec-tneq for Aromatic L-Amino Acid Decarboxylase Deficiency (AADC-D) and Comparison with Other Rare Disease One-Time Treatments in the United States

    Jul 1, 2025, 00:00

  • RWD152 Real-World Health-Related Quality of Life and Treatment Satisfaction in Patients With High-Risk Non-Muscle Invasive Bladder Cancer

    Jul 1, 2025, 00:00

  • P39 Cost-Effectiveness of Transthyretin Stabilizing Agents for the Treatment of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

    Jul 1, 2025, 00:00

  • HPR163 Inequities in Access to Oncology Drugs in Brazil - the Case of Public and Private Healthcare Systems

    Jul 1, 2025, 00:00

  • EE306 Healthcare Resource Utilization of Tafamidis Patients in the United States

    Jul 1, 2025, 00:00

  • MT36 Hospital Budget Impact Model of Patterned Frequency-Modulated Oral Stimulation in Preterm Infants

    Jul 1, 2025, 00:00

  • HSD109 Hospital-Level Effects on Cardiovascular Monitoring Among Cancer Patients Treated with Cardio-Toxic Therapies

    Jul 1, 2025, 00:00

  • PCR234 Health-Related Quality of Life in Individuals with Diagnosed Depression, Self-Reported Depression, and Non-Depressed: A Multi-Center Cross-Sectional Study

    Jul 1, 2025, 00:00

  • HPR109 Impact of Increased Patients' Out-of-Pocket Costs on Oral Anticoagulant Discontinuation among Medicare Beneficiaries with Atrial Fibrillation Treated with Apixaban

    Jul 1, 2025, 00:00

  • HPR157 Evaluating the Effect of Type of Insurance Coverage on Changes in Prescription Medication Utilization During the COVID-19 Pandemic

    Jul 1, 2025, 00:00

  • RWD138 Predictor of dispensing behavior for mental health treatments in Saudi Arabia

    Jul 1, 2025, 00:00

  • MT37 Comparative Effectiveness of Powered Surgical Stapling in Patients Undergoing Minimally Invasive Thoracic Surgery

    Jul 1, 2025, 00:00

  • HPR74 Analysis of Public Expenditure of Pharmaceutical Utilization of Female Infertility in Hungary in the Last Decade

    Jul 1, 2025, 00:00

  • HPR118 The Role of Invasive Diagnostics in Prior Authorization for MASH

    Jul 1, 2025, 00:00

  • EE278 A Systematic Scoping Review of Published Economic Analyses of Public Cord Blood Banking: Is It Time to Re-Assess?

    Jul 1, 2025, 00:00

  • RWD132 Onset of Cardiomyopathy and Cardiovascular Disease-Related Burden in Friedreich Ataxia: Real-World Data From Medical Claims

    Jul 1, 2025, 00:00

  • PCR74 Utility of Mobile Health Applications, Wearable Devices, and Patient Generated Health Data in Menopause Research

    Jul 1, 2025, 00:00

  • HSD41 Impact of Racial and Ethnic Disparities on Health-Related Quality of Life in Older Adults With Arthritis in the United States

    Jul 1, 2025, 00:00

  • PCR160 Real-World Evidence of Setmelanotide in Patients with Rare Melanocortin-4 Receptor Pathway Diseases: Baseline Findings from the RESTORE Longitudinal Survey Study

    Jul 1, 2025, 00:00

  • EE449 Cost-Effectiveness of Pembrolizumab as Treatment forFIGO 2014Stage III-IVA Cervical Cancer in the United States

    Jul 1, 2025, 00:00

  • P45 Is There Any difference in Preferences Between Patients and Physicians? Evidence From Anti-Hyperglycemic Medications Choices for Type 2 Diabetes

    Jul 1, 2025, 00:00

  • PCR256 Patient Perspectives on Communication With Clinicians: A Survey on Hospitalized Patient Experiences

    Jul 1, 2025, 00:00

  • EPH91 Conceptual Mapping of Health-Related Quality of Life, Quality of Life, and Wellbeing: A Systematic Review and Assessment of Commonly Used Patient Reported Outcomes Measures

    Jul 1, 2025, 00:00

  • EE378 Healthcare Resource Utilization and Associated Costs in Patients With Transthyretin Cardiac Amyloidosis and Non-amyloid Heart Failure

    Jul 1, 2025, 00:00

  • EE442 Assessing the Relationship Between Pruritus and Work Productivity Among Individuals With PBC and Pruritus: Results From the ITCH-E Study

    Jul 1, 2025, 00:00

  • P19 Advancing Equity in CAR T-Cell Therapy: An Analysis of Health Technology Assessments by Canada's Drug Agency and the National Institute for Health and Care Excellence

    Jul 1, 2025, 00:00

  • EPH146 Pre-Diagnostic Healthcare for People with Fragile X Syndrome

    Jul 1, 2025, 00:00

  • EE307 Population Impact Model of Faricimab and Aflibercept 8mg among US patients with Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration

    Jul 1, 2025, 00:00

  • RWD117 Concordance of ER and HER2 Status by Claims-Based Algorithm and Large Language Models (LLM) Abstracted Clinical Notes in Patients With Metastatic Breast Cancer (mBC)

    Jul 1, 2025, 00:00

  • HPR148 Payer Survey Uncovers Likely Increased Management Strategies Following Release of Initial 10 Drugs Selected for Price Negotiation

    Jul 1, 2025, 00:00

  • CO58 Progression-Free Survival and Objective Response Rates As Surrogate Endpoints for Overall Survival Among Patients With ROS1+ Locally Advanced or Metastatic Non-Small Cell Lung Cancer Receiving ROS1 Tyrosine Kinase Inhibitors

    Jul 1, 2025, 00:00

  • P14 Evaluating Fairness Across Machine Learning Algorithms in Health Models Incorporating Race/Ethnicity as Predictors

    Jul 1, 2025, 00:00

  • RWD95 Healthcare Cost and Resource Utilization among First Line (1L) Treated Patients with Metastatic Non-small Cell Lung Cancer (mNSCLC): Analysis of SEER-Medicare Linked Claims in the US

    Jul 1, 2025, 00:00

  • EPH49 Characteristics and Adherence of Patients Initiating Injectable Cabotegravir for HIV Treatment or Prevention

    Jul 1, 2025, 00:00

  • RWD109 Trends in the Global Drug Development Pipeline 2024

    Jul 1, 2025, 00:00

  • RWD26 Market Size and Dispensing Patterns for Rheumatoid Arthritis Medications in SUS (Brazil, 2019–2023)

    Jul 1, 2025, 00:00

  • EE303 The Time Value of Money driven by Early Disease-Modifying Interventions in Degenerative Disease

    Jul 1, 2025, 00:00

  • MSR22 Evaluating the Application of GPT-4o and Retrieval-Augmented Generation (RAG) for Assessing Risk of Bias and Study Quality in Systematic Literature Reviews (SLRs): Preliminary Findings from a Comparative Study

    Jul 1, 2025, 00:00

  • PT6 Comparison of Meaningful Score Difference Estimates From Longitudinal Item Response Theory and Anchor-Based Methods

    Jul 1, 2025, 00:00

  • HSD13 Exploring Oral Skeletal Muscle Relaxant Therapy in Adult Poststroke Patients in the US

    Jul 1, 2025, 00:00

  • HPR119 Geographical and Temporal Variations in Availability of National Price Negotiated Novel Anticancer Drugs: A Spatial Statistical Study Based on Two Cross-Sectional Datasets in China

    Jul 1, 2025, 00:00

  • PCR246 Preferences for Parkinson's Disease Treatments: A Scoping Literature Review

    Jul 1, 2025, 00:00

  • PCR102 Information-Seeking Behavior of Over-the-Counter Medication From 2012 to 2022 Based Google Trends Data in Hungary

    Jul 1, 2025, 00:00

  • PCR254 Symptom Burden of Acute Influenza Infection Among US Adults: An Interim Analysis of a Nationwide Prospective Study

    Jul 1, 2025, 00:00

  • RWD137 Real-World Treatment Patterns of First-Line (1L) Ibrutinib in Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (CLL/SLL): Insights into Therapy Interruptions, Discontinuation and Next Treatment

    Jul 1, 2025, 00:00

  • EE367 A Framework for Evaluating the Economic and Operational Impact of Adopting the Sentimag®platform for Lesion Localization and Sentinel Lymph Node Biopsy in Women with Breast Cancer

    Jul 1, 2025, 00:00

  • CO28 Understanding Racial Differences in Emergency Room Visits for Patients with Lupus

    Jul 1, 2025, 00:00

  • CO12 Long-term Health Outcomes in Patients With Moderate-to-Severe Ulcerative Colitis Treated With Guselkumab: a Model-based Projection

    Jul 1, 2025, 00:00

  • EE478 Healthcare Resource Utilization Among Fabry Disease Patients in the U.S.: Insightes From a Real-World Retrospective Study

    Jul 1, 2025, 00:00

  • HSD11 Treatment Patterns in the Management of Vitiligo in a Colombian HMO During 2015-2023: A Real-World Data Study

    Jul 1, 2025, 00:00

  • RWD72 Utilizing NLP to Enhance EHR Data Abstraction Accuracy in Waldenström Macroglobulinemia

    Jul 1, 2025, 00:00

  • EE491 Automating Health Economic Model Quality Check With a Model Generator

    Jul 1, 2025, 00:00

  • PT12 Large-Language Models to Complement and Augment Literature Review: Hi! How Can I Help You?

    Jul 1, 2025, 00:00

  • EE357 Cost-Effectiveness Analysis of Technosphere Insulin (TI) Versus Insulin Aspart Injection in Type 1 Diabetes Management: Perspective From the US Healthcare System

    Jul 1, 2025, 00:00

  • MSR71 Joint Modeling for Clinical Interpretation of ctDNA Tumor Methylation Dynamics During Longitudinal Monitoring

    Jul 1, 2025, 00:00

  • RWD73 Use of Sensitivity Analysis to Address Potential Missing Data and Selection Bias from Linked Genomics Datasets in a Real-World Study of Patients Receiving Immune-Checkpoint Inhibitors for Metastatic Melanoma

    Jul 1, 2025, 00:00

  • Table of Contents

    Jul 1, 2025, 00:00

  • RWD54 Characteristics of Adults With Type 2 Diabetes Who Are Not Treated With A Glucose-Lowering Agent: A Retrospective Cohort Study

    Jul 1, 2025, 00:00

  • P29 Real-World Treatment Patterns of Advanced Melanoma in the United States

    Jul 1, 2025, 00:00

  • PCR238 Development of a Conceptual Model Supporting a Clinical Outcome Assessment Strategy for Acquired Angioedema Due to C1 Inhibitor Deficiency

    Jul 1, 2025, 00:00

  • EE411 Estimating the Potential Cost-Effectiveness of Long-Acting Naltrexone versus Oral Naltrexone for Alcohol Use Disorder

    Jul 1, 2025, 00:00

  • HTA93 Moving Beyond Partitioned Survival Models in Oncology Submissions: Incorporation of Canada's Drug Agency Guidance on Model Structure

    Jul 1, 2025, 00:00

  • HPR71 Evaluating the ICER Special Report in the Context of Medicare Drug Price Negotiations: Implications for Manufacturer Pricing and Evidence Strategies

    Jul 1, 2025, 00:00

  • CO26 A Systematic Review and Meta-Analysis of da Vinci Robotic-Assisted Surgery vs. Laparoscopic or Open Approaches for Benign Colon Conditions

    Jul 1, 2025, 00:00

  • RWD124 Healthcare Resource Utilization for Medicare Patients with Non-Cystic Fibrosis Bronchiectasis (NCFB) and Exacerbations Coinfected with Pseudomonas aeruginosa

    Jul 1, 2025, 00:00

  • EE264 Number Needed to Treat and Associated Costs Per Additional Responder of Biologic Therapies in Adult Patients With Moderate To Severe Atopic Dermatitis

    Jul 1, 2025, 00:00

  • P59 Application of Bayesian Meta-Analysis in Synthesizing Health State Utility Values for QALY Estimation in Health Economic Evaluations: A Case Study on Advanced Neuroendocrine Tumors

    Jul 1, 2025, 00:00

  • EE273 Cost-Effectiveness of Integrating Artificial Intelligence-Based Retinal Photographic Cardiovascular Disease risk Assessment with Diabetic Retinopathy Screening Programmes: A Multi-Country Analysis

    Jul 1, 2025, 00:00

  • RWD145 Use of the Glucocorticoid Toxicity Index-Metabolic Domains Instrument to Quantify Glucocorticoid Toxicity in Adults With Chronic Inflammatory Demyelinating Polyneuropathy Using Electronic Health Records in the United States

    Jul 1, 2025, 00:00

  • MSR16 AI-Driven Evidence Synthesis: Leveraging RAG and Multi-Agentic Approach to Conduct Disease Landscape Assessments

    Jul 1, 2025, 00:00

  • EE397 Cost-Effectiveness of a Potential Policy to Ban Alcohol Advertising in Australia: A Modeling Study

    Jul 1, 2025, 00:00

  • PCR209 Impact of COVID-19 on Quality of Life and Work Productivity Among Symptomatic US Adults Testing Positive for SARS-CoV-2: Interim Analysis of a Nationwide Longitudinal Study

    Jul 1, 2025, 00:00

  • EE493 Cost Effectiveness of Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients in China

    Jul 1, 2025, 00:00

  • EE353 Cost-Effectiveness Analysis of Regorafenib Versus FTD-TPI + Bevacizumab in Patients with Metastatic Colorectal Cancer from the Perspective of the Brazilian Supplementary Health System

    Jul 1, 2025, 00:00

  • MSR86 Machine Learning for Predictive Modeling of Hospitalization Risk in Myasthenia Gravis Patients Using the MGFA Global Patient Registry: Addressing Imbalanced Data in Real-World Evidence Scenarios

    Jul 1, 2025, 00:00

  • CO47 Comparative Effectiveness of Novel vs Established Therapies in Obstructive Hypertrophic Cardiomyopathy (HOCM): Insights From a US Electronic Health Records (EHR) Study

    Jul 1, 2025, 00:00

  • P60 Feasibility of Replicating a Published Health Economic Model From an ICER Report Using Generative AI

    Jul 1, 2025, 00:00

  • EE508 Abnormal Uterine Bleeding in Brazil: Comparison of 52mg LNG-IUS and Histerectomy

    Jul 1, 2025, 00:00

  • PCR110 Exploring Treatment Preferences for Rare Diseases: A Systematic Review of Quantitative Preference Studies

    Jul 1, 2025, 00:00

  • RWD110 Validation of Real-World Pathologic Complete Response in Early Stage Triple Negative Breast Cancer

    Jul 1, 2025, 00:00

  • EPH151 Depression Literacy in the Middle East and North Africa: A Scoping Review

    Jul 1, 2025, 00:00

  • EE262 Epidemiological and Economic Analysis of Hospitalizations for Cellulitis and Erysipelas From the Perspective of a Brazilian Health Insurance Company

    Jul 1, 2025, 00:00

  • EPH181 Recent Evidence on the Comprehensive Burden of Pediatric Invasive Meningococcal Disease in the United States: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • HTA24 Long-term Predictions for Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer: 40-year Period Extrapolation

    Jul 1, 2025, 00:00

  • HTA85 Developing a Value Assessment Framework for Modified New Drugs In China

    Jul 1, 2025, 00:00

  • HTA97 Is the Assumption of Treatment Waning Applied Consistently Across Canada’s Drug Agency Reimbursement Reviews? Reviewing Pharmacoeconomic Assessments of Disease Modifying Therapies for the Treatment of Multiple Sclerosis

    Jul 1, 2025, 00:00

  • MSR81 Imputing Breast Cancer Stage in a Large EHR Dataset: Light Gradient Boosting Machine Algorithm and Explainable Artificial Intelligence

    Jul 1, 2025, 00:00

  • EE523 Incremental Annual State Level Cost Of Asthma And Future Projections In The United States

    Jul 1, 2025, 00:00

  • EPH92 Transfusion Needs For Patients With Myelofibrosis In Latin America

    Jul 1, 2025, 00:00

  • RWD116 Training and Validation of CARAaiTM: A Multi LLM Platform and Data Model to Address Oncology-Specific Challenges in Clinical Data Extraction

    Jul 1, 2025, 00:00

  • HSD96 Conceptualisation and the Role of Market Access in Pharmaceutical Industry: A Qualitative Study

    Jul 1, 2025, 00:00

  • PCR181 Patient-Reported Outcomes As Important Predictors of Apremilast Persisten A Pooled Analysis of Real-World Data

    Jul 1, 2025, 00:00

  • EE279 Economic Burden of Erythropoietic Protoporphyria (EPP) and X-linked Protoporphyria (XLP): A Large United States (US) Nationwide Claims Analysis

    Jul 1, 2025, 00:00

  • PCR196 Hypophosphatasia (HPP) Patient Treatment Experien A Mixed Methods Study Concept

    Jul 1, 2025, 00:00

  • EE452 Evaluating the Cost-Benefit of Automated Dispensing Cabinets in Long-Term Care and Closed-Door Pharmacies

    Jul 1, 2025, 00:00

  • EE396 Cost Per Responder Analysis of Patients With 3 Previous Lines and Lenalidomide Refractory Multiple Myeloma Who Received Cilta-Cel in the Brazilian Private Health System

    Jul 1, 2025, 00:00

  • PT42 Designing Value-Based Dental Insuran A Multicriteria Decision Analysis

    Jul 1, 2025, 00:00

  • EE329 Impact of Route of Administration and HCP- or Self-Administration on Pricing of Non-Oncology Orphan Products, 2015-2024

    Jul 1, 2025, 00:00

  • HTA53 The Dynamic Nature of Network Meta-Analysis: How Data Updates Could Influence Health Technology Assessment

    Jul 1, 2025, 00:00

  • CO6 Comparative Efficacy and Safety of Adjunctive CT-152 in Major Depressive Disorder: A Frequentist Network Meta-Analysis

    Jul 1, 2025, 00:00

  • MT34 Effectiveness of Digital Care Platforms for Cancer Patients: A Systematic Review and Meta-Analysis

    Jul 1, 2025, 00:00

  • EPH177 Advancing Health Economics: Incorporating AMR Impact Into Pneumococcal Vaccine Assessment

    Jul 1, 2025, 00:00

  • EE276 Economic Evaluation of Detection, Treatment, and Prevention Interventions for Perinatal Mood and Anxiety Disorders: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • PCR148 Study of Patient Preferences Regarding a New Class of Antihypertensive Medications: A Discrete Choice Experiment in Ukraine

    Jul 1, 2025, 00:00

  • RWD85 Short- and Longer-Term Healthcare Resource Utilization and Related Costs of Stroke in the Brazilian Private Market from 2019 to 2023

    Jul 1, 2025, 00:00

  • MSR151 Group-Based Trajectory Modeling to Identify Longitudinal Patterns of Adherence to Statins in Older Adults on Concomitant Triple Therapy (Oral Antidiabetic, RAS Antagonists, Statins)

    Jul 1, 2025, 00:00

  • PCR122 A Critical Review of Existing Shared Decision-Making Measuring Approaches in Studies Using the Medical Expenditure Panel Survey (MEPS)

    Jul 1, 2025, 00:00

  • PCR144 Weight Loss Program (WLP): Clinical and Economic Impact Analysis (CEIA) Preliminary Data From an MCDA Related to the Adherence of Obese Patients' Study in BraziL/LATAM/LMIC

    Jul 1, 2025, 00:00

  • RWD50 Real-World Healthcare Resource Utilization and Related Costs Associated with Ovarian Cancer in the Brazilian Private Market

    Jul 1, 2025, 00:00

  • MSR30 Evaluating Generative AI in Replicating Health Economic Models: A Case Study on Ulcerative Colitis

    Jul 1, 2025, 00:00

  • HTA20 Drivers of High ICERs in SMC Appraisals

    Jul 1, 2025, 00:00

  • MT24 Health Equity and Robotic-Assisted Surgery with the da Vinci Surgical Systems: A Literature Review

    Jul 1, 2025, 00:00

  • PCR233 Physician, Patient and Caregiver Concordance in a Real-World US Generalized Myasthenia Gravis Population

    Jul 1, 2025, 00:00

  • HSD61 Impact of Using Telehealth in Primary Care on Healthcare Resource Utilization, Costs, and Medication Adherence in Diabetic Patients

    Jul 1, 2025, 00:00

  • MT20 A Bibliometric Analysis to Estimate the Reach and Impact of the Peterson Health Technology Institute's Digital Health Value Assessments

    Jul 1, 2025, 00:00

  • RWD51 Trends in the Uptake of SGLT-2 Inhibitors in Type 2 Diabetes Mellitus With Comorbid Cardiovascular Conditions: A Longitudinal Analysis

    Jul 1, 2025, 00:00

  • HPR106 Regional Differences in IVF Utilization Rates in Hungary in the Last Decade

    Jul 1, 2025, 00:00

  • EE253 Evaluation of Real-World Total Healthcare Costs Difference Between Subcutaneous and Intravenous Formulations of Pertuzumab and Trastuzumab in HER2+ Breast Cancer Patients

    Jul 1, 2025, 00:00

  • PCR208 Hematologist-Oncologist Preferences for Treating Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) using Tyrosine Kinase Inhibitors in Combination with Chemotherapy: A Discrete Choice Experiment

    Jul 1, 2025, 00:00

  • PCR172 Knowledge and Willingness to Self-Sampling About Cervical Cancer Screening in Zala County, Hungary

    Jul 1, 2025, 00:00

  • SA10 Improving the Face Validity and Clinical Relevance of a Cancer Epidemiology Microsimulation Model Using a Novel Advisory Group Approach

    Jul 1, 2025, 00:00

  • PCR207 The Effect of Public Health Awareness Campaigns on Prostate Cancer-Related Online Information-Seeking Behavior: A Hungarian Experience

    Jul 1, 2025, 00:00

  • RWD87 How Well Does Hospital Billing Data Estimate Readmissions and Revision Risks After Spinal Fusion Surgery, Compared to Hospital Billing Linked to Claims Data?

    Jul 1, 2025, 00:00

  • EE444 Economic Analysis of the Use of Polyhexamethylene Biguanide Associated with Betaine (PHMB) Gel Compared to Silver Sulfadiazine in the Treatment of Second-Degree Burns

    Jul 1, 2025, 00:00

  • MSR78 Leveraging a Novel Mixed-Methods Approach to Deepen Insights From Exit Interviews and Trial Data in a Randomized Trial of Cancer Cachexia

    Jul 1, 2025, 00:00

  • MSR130 Using Real-World Data and Machine Learning to Identify Patients at Highest Risk for Hospitalization Following Respiratory Syncytial Virus Infection

    Jul 1, 2025, 00:00

  • HPR123 Socioeconomic Vulnerabilities and Postpartum Depression: Assessingthe Aftermath of Dobbs v. Jackson in Trigger and Non-Trigger States

    Jul 1, 2025, 00:00

  • EPH72 Pattern of Opioid Prescriptions Among Patients With Breast, Lung, and Colorectal Cancer Diagnosed With Chronic Non-Malignant Pain

    Jul 1, 2025, 00:00

  • MSR35 Training and Validation Methods of Artificial Intelligence Tools For Automated Systematic Reviews In Pharmacoepidemiology and Health Technology Assessment: A Systematic Review

    Jul 1, 2025, 00:00

  • EE293 A Comparative Assessment of ICER-Sponsored Versus Pharma-Sponsored Cost-Effectiveness Analysis

    Jul 1, 2025, 00:00

  • EE527 Therapeutic Options for Changing the Course of Disease in Generalized Myasthenia Gravis (gMG) and Fiscal Consequences for the Canadian Governments

    Jul 1, 2025, 00:00

  • EE308 Incidence of Opioid Use Disorder and the Associated Economic Burden Among People Managing Acute Pain With Prescription Opioids in the United States in Commercial, Medicare, and Medicaid Populations

    Jul 1, 2025, 00:00

  • PCR126 Balancing Vulnerability and Freedom: Perspectives on HIV Cure-Related Trials With Analytical Treatment Interruption Among People With HIV and Healthcare Practitioners in the United States

    Jul 1, 2025, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8 (current)
  • 9
  • 10
  • »